BIOMAT Database Logo BIOMAT Database Logo

Diabetes and risk of adverse events with calcium antagonists. 1998

M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Diabetes and risk of adverse events with calcium antagonists.
October 1998, Diabetes care,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Long-acting calcium antagonists linked to CV adverse events.
November 2000, Geriatrics,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
January 1998, Lancet (London, England),
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Adverse reactions with calcium antagonists.
January 1983, Hypertension (Dallas, Tex. : 1979),
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Calcium antagonists and cardiovascular risk in diabetes.
November 1998, The American journal of cardiology,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Critique of a biologic mechanism linking calcium antagonists to increased risk for cardiovascular events in diabetes.
November 1998, The American journal of cardiology,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Calcium antagonists--adverse drug interactions.
December 1987, Cardiovascular drugs and therapy,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Adverse reactions to calcium antagonists.
February 1983, Drugs,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Risk for adverse events among patients receiving intravenous histamine2-receptor antagonists.
December 1993, The Annals of pharmacotherapy,
M Pahor, and S B Kritchevsky, and G Zuccala, and J M Guralnik
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.
January 2015, Annals of surgery,
Copied contents to your clipboard!